3. Senolytic Drugs

Senolytic drugs target and eliminate senescent cells—cells that have stopped dividing and accumulate with age, contributing to tissue dysfunction and inflammation. In mice, removing these cells has improved health and extended lifespan. For instance, a study demonstrated that eliminating senescent cells in aged mice led to a significant increase in their lifespan and improved overall health. (science.org)
In humans, clinical trials are underway to assess the safety and efficacy of senolytic therapies. A notable trial investigated the combination of dasatinib and quercetin, two compounds identified as senolytics, in patients with idiopathic pulmonary fibrosis. The results indicated that this combination was feasible and well-tolerated, suggesting potential for broader applications. (science.org)
While these findings are promising, further research is necessary to fully understand the long-term effects and therapeutic potential of senolytic drugs in humans. (science.org)